Jennifer Zibuda

Jennifer Zibuda

Keine laufenden Positionen mehr

Health Technology

Ursprung des Netzwerks ersten Grades von Jennifer Zibuda

EinheitArt der EinheitIndustrie
Public Company Biotechnology 6

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Jennifer Zibuda

UnternehmenSektorVerknüpfte PersonenHauptposition
BIO-TECHNE CORPORATION Biotechnology

Christopher Henney

Director/Board Member

Investment Managers

Helen Kim

Private Equity Investor

College/University

Hideki Garren

Undergraduate Degree

University of California, Los Angeles College/University

Hideki Garren

Doctorate Degree

Investment Managers

Helen Kim

Corporate Officer/Principal

Investment Managers

Helen Kim

Private Equity Investor

The University of Chicago Booth School of Business College/University

Helen Kim

Graduate Degree

Protego Therapeutics, Inc.

Helen Kim

Director/Board Member

COYA THERAPEUTICS, INC. Biotechnology

Hideki Garren

Director/Board Member

Biotechnology

Helen Kim

Director/Board Member

Medical/Nursing Services

Helen Kim

Director/Board Member

Biotechnology

Helen Kim

Director/Board Member

Pharmaceuticals: Major

Helen Kim

Director/Board Member

Pharmaceuticals: Major

Helen Kim

Director/Board Member

Miscellaneous Commercial Services

Helen Kim

Director/Board Member

Stanford University College/University

Hideki Garren

Corporate Officer/Principal

Pharmaceuticals: Major

Hideki Garren

Corporate Officer/Principal

APPLIED MOLECULAR TRANSPORT INC. Biotechnology

Helen Kim

Director/Board Member

ARYA SCIENCES ACQUISITION CORP V Financial Conglomerates

Sanjiv Patel

Director/Board Member

College/University

Radhika Tripuraneni

Graduate Degree

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Radhika Tripuraneni

Chief Tech/Sci/R&D Officer

MYOKARDIA, INC. Pharmaceuticals: Major

Radhika Tripuraneni

Corporate Officer/Principal

University of Missouri College/University

Radhika Tripuraneni

Doctorate Degree

ALLERGAN, INC. Pharmaceuticals: Major

Sanjiv Patel

Corporate Officer/Principal

University of Cambridge College/University

Sanjiv Patel

Graduate Degree

Biotechnology

Hideki Garren

Corporate Officer/Principal

RELAY THERAPEUTICS, INC. Biotechnology

Sanjiv Patel

Chief Executive Officer

The Royal College of Surgeons of England College/University

Sanjiv Patel

Corporate Officer/Principal

INSEAD College/University

Sanjiv Patel

Masters Business Admin

University of London College/University

Sanjiv Patel

Doctorate Degree

ALLERGAN PLC Pharmaceuticals: Major

Sanjiv Patel

Corporate Officer/Principal

Pharmaceuticals: Major

Hideki Garren

Corporate Officer/Principal

Biotechnology

Helen Kim

Director/Board Member

EXICURE, INC. Biotechnology

Helen Kim

Director/Board Member

Biotechnology

Christopher Henney

Founder

Pharmaceuticals: Major

Christopher Henney

Chairman

Miscellaneous Commercial Services

Christopher Henney

Corporate Officer/Principal

College/University

Christopher Henney

Corporate Officer/Principal

The Johns Hopkins University College/University

Christopher Henney

Corporate Officer/Principal

MYMETICS CORPORATION Pharmaceuticals: Major

Christopher Henney

Director/Board Member

Pharmaceuticals: Other

Christopher Henney

Founder

Pharmaceuticals: Major

Helen Kim

Chief Executive Officer

SAREPTA THERAPEUTICS, INC. Pharmaceuticals: Major

Christopher Henney

Director/Board Member

University of Birmingham College/University

Christopher Henney

Doctorate Degree

CYCLACEL PHARMACEUTICALS, INC. Pharmaceuticals: Major

Christopher Henney

Chairman

Statistik

International

Vereinigte Staaten 40
Vereinigtes Königreich 5
Schweiz 4
Kanada 3
Frankreich 2

Sektoral

Health Technology 28
Consumer Services 14
Finance 5
Health Services 3
Commercial Services 3

Operativ

Director/Board Member 34
Corporate Officer/Principal 19
Chairman 8
Independent Dir/Board Member 8
Chief Tech/Sci/R&D Officer 5
  1. Börse
  2. Insiders
  3. Jennifer Zibuda
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT